Scientific Publications: 2006

Preclinical Studies:

  1. Kijak GH, Tovanabutra S, Sanders-Buell E, Watanaveeradej V, de Souza MS, Nelson KE, Ketsararat V, Gulgolgarn V, Wera-Arpachai M, Sriplienchan S Khamboonrueng C, Birx DL, Robb ML, McCutchan FE. Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2. Virology. 2006 Sep 25.
  2. Watanaveeradej V, Benenson MW, Souza MD, Sirisopana N, Nitayaphan S, Tontichaivanich C, Amphaipit R, Renzullo PO, Brown AE, McNeil JG, Robb ML, Birx DL, Tovanabutra S, Carr JK, McCutchan FE. Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping. AIDS Res Hum Retroviruses. 2006 Aug;22(8):801-7.
  3. Herbinger KH, Gerhardt M, Piyasirisilp S, Mloka D, Arroyo MA, Hoffmann O, Maboko L, Birx DL, Mmbando D, McCutchan FE, Hoelscher M. Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania. AIDS Res Hum Retroviruses. 2006 Jul;22(7):599-606.
  4. Torimiro JN, Carr JK, Wolfe ND, Karacki P, Martin MP, Gao X, Tamoufe U, Thomas A, Ngole EM, Birx DL, McCutchan FE, Burke DS, Carrington M. HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype. Tissue Antigens. 2006 Jan; 67(1):30-7.
  5. Brown BK, Karasavva N, Beck Z, Matyas GR, Birx DL, Polonis VR, Alving CR. Monoclonal antibodies to phosphatidylinositol phosphate neutralize HIV-1: role of phosphate binding subsites. J Virol. 2006 Dec 6.
  6. Sathaliyawala T, Rao M, Maclean DM, Birx DL, Alving CR, Rao VB. Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines. J Virol. 2006 Aug;80(15):7688-98.
  7. Alving CR, Beck Z, Karasavva N, Matyas GR, Rao M. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies (Review). Mol Membr Biol. 2006 Nov-Dec;23(6):453-65.
  8. Shivachandra SB, Li Q, Peachman KK, Matyas GR, Leppla SH, Alving CR, Rao M,. Multicomponent anthrax toxin display and delivery using bacteriophage T4. Vaccine. 2006 Oct 17; [Epub ahead of print]
  9. Alving CR. Antibodies to lipids and liposomes: immunology and safety. J Liposome Res. 2006;16(3):157-66.
  10. Peachman KK, Rao M, Alving CR, Burge R, Leppla SH, Rao VB, Matyas GR. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infect Immun. 2006 Jan; 74(1):794-7.
  11. Shivachandra SB, Rao M, Janosi L, Sathaliyawala T, Matyas GR, Alving CR, Leppla SH, Rao VB. In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins. Virology. 2006 Feb 5; 345(1):190-8. Epub 2005 Nov 28.
  12. Szebeni J, Baranyi L, Savay S, Bodo M, Milosevits J, Alving CR, Bunger R. Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function. Am J Physiol Heart Circ Physiol. 2006 Mar; 290(3):H1050-8. Epub 2005 Oct 7.
  13. Li M, Salazar-Gonzalez JF, Derdeyn CA, Morris L, Williamson C, Robinson JE, Decker JM, Li Y, Salazar MG, Polonis VR, Mlisana K, Karim SA, Hong K, Greene KM, Bilska M, Zhou J, Allen S, Chomba E, Mulenga J, Vwalika C, Gao F, Zhang M, Korber BT, Hunter E, Hahn BH, Montefiori DC. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J Virol. 2006 Dec;80(23):11776-90. Epub 2006 Sep 13.
  14. Betts MR, Gray CM, Cox JH, Ferrari G. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development. Expert Rev Vaccines. 2006 Aug;5 (4):505-16. Review.
  15. Visawapoka U, Tovanabutra S, Currier JR, Cox JH, Mason CJ, Wasunna M, Ponglikitmongkol M, Dowling WE, Robb ML, Birx DL, McCutchan FE. Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2. AIDS Res Hum Retroviruses. 2006 Jul;22(7):695-702.
  16. Currier JR, Visawapoka U, Tovanabutra S, Mason CJ, Birx DL, McCutchan FE, Cox JH. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response. BMC Immunol. 2006 Apr 18;7:8.
  17. Cox JH, Ferrari G, Janetzki S. Measurement of cytokine release at the single cell level using the ELISPOT assay. Methods. 2006 Apr; 38(4):274-82.
  18. Sun P, Celluzzi CM, Marovich M, Subramanian H, Eller M, Widjaja S, Palmer D, Porter K, Sun W, Burgess T. CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cell-mediated immunopathology. J Immunol. 2006 Nov 1; 177(9): 6497-503.
  19. Khurana S, Needham J, Mathieson B, Rodriguez-Chavez IR, Catanzaro AT, Bailer RT, Kim J, Polonis V, Cooper DA, Guerin J, Peterson ML, Gurwith M, Nguyen N, Graham BS, Golding H. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies. J Virol. 2006 Mar; 80(5):2092-9.
  20. Martin NC, Pardo J, Simmons M, Tjaden JA, Widjaja S, Marovich MA, Sun W, Porter KR, Burgess TH. An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies J Virol Methods. 2006 Jun; 134 (1-2):74-85. Epub 2006 Jan 18.
  21. W Kantakamalakul, M de Souza, S Bejrachandra, S Ampol, J Cox, R Sutthent Identification of a novel HIV-1 CRF01_AE cytotoxic T lymphocyte (CTL) epitope restricted by HLA-Cw0602 allele and a novel HLA-A0206/peptide restriction. 2006 AIDS Research and Human Retroviruses 22: 1271-1282.

Epidemiology and Threat Assessment Surveillance:

  1. McCutchan FE. Global epidemiology of HIV. J Med Virol. 2006;78 Suppl 1:S7-S12.
  2. Saad MD, Shcherbinskaya AM, Nadai Y, Kruglov YV, Antonenko SV, Lyullchuk MG, Kravchenko ON, Earhart KC, Sanchez JL, Birx DL, Carr JK. Molecular epidemiology of HIV Type 1 in Ukraine: birthplace of an epidemic. AIDS Res Hum Retroviruses. 2006 Aug; 22(8):709-14.
  3. Pando MA, Eyzaguirre LM, Segura M, Bautista CT, Marone R, Ceballos A, Montano SM, Sanchez JL, Weissenbacher M, Avila MM, Carr JK. First report of an HIV-1 triple recombinant of subtypes B, C and F in Buenos Aires, Argentina. Retrovirology. 2006 Sep 7;3:59.
  4. Pando MA, Bautista CT, Maulen S, Duranti R, Marone R, Rey J, Vignoles M, Eirin ME, Biglione MM, Griemberg G, Montano SM, Carr JK, Sanchez JL, Avila MM. Epidemiology of human immunodeficiency virus, viral hepatitis (B and C), treponema pallidum, and human T-cell lymphotropic I/II virus among men who have sex with men in Buenos Aires, Argentina. Sex Transm Dis. 2006 May;33(5):307-13.
  5. Pando MA, Berini C, Bibini M, Fernandez M, Reinaga E, Maulen S, Marone R, Biglione M, Montano SM, Bautista CT, Weissenbacher M, Sanchez JL, Avila MM. Prevalence of HIV and other sexually transmitted infections among female commercial sex workers in Argentina. Am J Trop Med Hyg. 2006 Feb;74 (2):233-8.
  6. Laguna-Torres VA, Perez-Bao J, Chauca G, Sovero M, Blichtein D, Chunga A, Flores W, Retamal A, Mendoza S, Cruz M, Monge Z, Lavalle M, Gutierrez J, Malaga J, Soto E, Loayza N, Bolivar D, Reyna R, Mendoza C, Ore M, Gonzalez J, Suarez M, Montano SM, Sanchez JL, Sateren W, Bautista CT, Olson JG, Xueref S. Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru. J Clin Virol. 2005 Dec;34 Suppl 2:S61-8.
  7. Todd CS, Earhart KC, Botros BA, Khakimov MM, Giyasova GM, Bautista CT, Carr JK, Sanchez JL. Prevalence and correlates of risky sexual behaviors among injection drug users in Tashkent, Uzbekistan. AIDS Care. 2007 Jan;19 (1):122-9.
  8. Bruckova M, Bautista CT, Graham RR, Maly M, Vandasova J, Presl J, Sumegh L, Chapman GD, Carr JK, Sanchez JL, Earhart KC. HIV infection among commercial sex workers and injecting drug users in the Czech Republic. Am J Trop Med Hyg. 2006 Nov;75 (5):1017-20.
  9. Nelson A, Press N, Bautista CT, Arevalo J, Quiroz C, Calderon M, Campos K Bryant A, Shantz-Dunn J, Dahodwala N, Vera M, Vivar A, Saito M, Gilman RH. Prevalence of Sexually Transmitted Infections and High-Risk Sexual Behaviors in Heterosexual Couples Attending Sexually Transmitted Disease Clinics in Peru. Sex Transm Dis. 2006 Oct 25; [Epub ahead of print]
  10. Lama JR, Lucchetti A, Suarez L, Laguna-Torres VA, Guanira JV, Pun M, Montano SM, Celum CL, Carr JK, Sanchez J, Bautista CT, Sanchez JL; Peruvian HIV Sentinel Surveillance Working Group. Association of herpes simplex virus type 2 infection and syphilis with human Immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis. 2006 Nov 15; 194 (10): 1459-66. Epub 2006 Oct 10.
  11. Todd CS, Alibayeva G, Sanchez JL, Bautista CT, Carr JK, Earhart KC. Utilization of contraception and abortion and its relationship to HIV infection among female sex workers in Tashkent, Uzbekistan. Contraception. 2006 Oct; 74(4):318-23. Epub 2006 Jun 30.
  12. Bautista CT, Sateren WB, Sanchez JL, Rathore Z, Singer DE, Birx DL, Scott PT. HIV incidence trends among white and African- American active duty United States Army personnel (1986-2003). J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):351-5.
  13. Eyzaguirre L, Bautista CT, Ayala C, Acosta J, Negrete M, Sateren WB, Montano SM, Sanchez JL, Carr JK. First case of HIV Type 1 subtype F among men who have sex with men in Colombia. AIDS Res Hum Retroviruses. 2006 Aug; 22(8): 808-11.
  14. Todd CS, Alibayeva G, Khakimov MM, Sanchez JL, Bautista CT, Earhart KC. Prevalence and Correlates of Condom Use and HIV Testing Among Female Sex Workers in Tashkent, Uzbekistan: Implications for HIV Transmission. AIDS Behav. 2006 Aug 15; [Epub ahead of print]
  15. Sateren WB, Foglia G, Renzullo PO, Elson L, Wasunna M, Bautista CT, Birx DL. Epidemiology of HIV-1 infection in agricultural plantation residents in Kericho, Kenya: preparation for vaccine feasibility studies. J Acquir Immune Defic Syndr. 2006 Sep;43(1):102-6.
  16. Bautista CT, Sanchez JL, Montano SM, Laguna-Torres A, Suarez L, Sanchez J, Campos P, Gallardo C, Mosquera C, Villafane M, Aguayo N, Avila MM, Weissenbacher M, Ramirez E, Child R, Serra M, Aponte C, Mejia A, Velazques N, Gianella A, Perez J, Olson JG, Carr JK. Seroprevalence of and risk factors for HIV-1 infection among female commercial sex workers in South America. Sex Transm Infect. 2006 Aug; 82(4): 311-6.
  17. Saito M, Pan WK, Gilman RH, Bautista CT, Bamrah S, Martin CA, Tsiouris SJ, Arguello DF, Martinez-Carrasco G. Comparison of altitude effect on Mycobacterium tuberculosis infection between rural and urban communities in Peru. Am J Trop Med Hyg. 2006 Jul; 75(1):49-54.
  18. Sanchez JL, Todd CS, Bautista CT, Botros BA, Khakimov MM, Giyasova GM, Yakubov SK, Abdulaeva MA, Saad MD, Graham RR, Carr JK, Earhart KC. High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004. Drug Alcohol Depend. 2006 Apr; 82 Suppl 1:S15-22.
  19. Bautista CT, Sateren WB, Singer DE, Carr JK, Birx DL, Sanchez JL. Trends in HIV prevalence among white and African-American civilian applicants for United States Military Service, 1985 to 2003. J Acquir Immune Defic Syndr. 2006 May;42(1):68-74.
  20. Sanchez GI, Bautista CT, Eyzaguirre L, Carrion G, Arias S, Sateren WB, Negrete M, Montano SM, Sanchez JL, Carr JK. Molecular epidemiology of human immunodeficiency virus-infected individuals in Medellin, Colombia. Am J Trop Med Hyg. 2006 Apr; 74(4):674-7.
  21. Todd CS, Khakimov MM, Alibayeva G, Abdullaeva M, Giyasova GM, Saad MD, Botros BA, Bautista CT, Sanchez JL, Carr JK, Earhart KC. Prevalence and correlates of human immunodeficiency virus infection among female sex workers in Tashkent, Uzbekistan. Sex Transm Dis. 2006 Aug; 33(8): 496-501.
  22. Ramirez-Cardich ME, Kawai V, Oberhelman RA, Bautista CT, Castillo ME, Gilman RH. Clinical correlates of tuberculosis co-infection in HIV-infected children hospitalized in Peru Int J Infect Dis. 2006 Jul;10(4):278-81. Epub 2006 Mar 15.
  23. Ryan JR, Mbui J, Rashid JR, Wasunna MK, Kirigi G, Magiri C, Kinoti D, Ngumbi PM, Martin SK, Odera SO, Hochberg LP, Bautista CT, Chan AS. Spatial clustering and epidemiological aspects of visceral leishmaniasis in two endemic villages, Baringo District, Kenya. Am J Trop Med Hyg. 2006 Feb; 74(2): 308-17.
  24. Bautista CT, Chan AS, Ryan JR, Calampa C, Roper MH, Hightower AW, Magill AJ. Epidemiology and spatial analysis of malaria in the northern peruvian amazon. Am J Trop Med Hyg. 2006 Dec; 75(6): 1216-1222.
  25. Kawai V, Soto G, Gilman RH, Bautista CT, Caviedes L, Huaroto L, Ticona E, Ortiz J, Tovar M, Chavez V, Rodriguez R, Escombe AR, Evans CA. Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg. 2006 Dec; 75(6):1027-1033.
  26. Zunt JR, Montano SM, Beck I, Alarcon JO, Frenkel LM, Bautista CT, Price R, Longstreth WT. Human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis: Viral load and muscle tone are correlated. J Neurovirol. 2006 Dec;12(6):466-71.
  27. Griemberg G, Bautista CT, Pizzimenti MC, Orfus G, Alonso B, Fernandez T, Cando O, Martinez Peralta L. High prevalence of syphilis-HIV co-infection at four hospitals of the city of Buenos Aires, Argentina. Rev Argent Microbiol. 2006 Jul-Sep;38(3):134-6.
  28. Bruckova M, Bautista CT, Graham RR, Maly M, Vandasova J, Presl J, Sumegh L, Chapman GD, Carr JK, Sanchez JL, Earhart KC. Short report: HIV infection among commercial sex workers and injecting drug users in the Czech Republic. Am J Trop Med Hyg. 2006 Nov;75(5):1017-20.

Clinical Studies:

  1. Follmann D, Duerr A, Tabet S, Gilbert P, Moodie Z, Fast P, Cardinali M, Self S. J Acquir Immune Defic Syndr. 2006 Oct 30; [Epub ahead of print Endpoints and Regulatory Issues in HIV Vaccine Clinical Trials: Lessons From a Workshop.]
  2. Ecker JA, Massire C, Hall TA, Ranken R, Pennella TT, Agasino Ivy C, Blyn LB, Hofstadler SA, Endy TP, Scott PT, Lindler L, Hamilton T, Gaddy C, Snow K, Pe M, Fishbain J, Craft D, Deye G, Riddell S, Milstrey E, Petruccelli B, Brisse S, Harpin V, Schink A, Ecker DJ, Sampath R, Eshoo MW. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol. 2006 Aug; 44(8):2921-32.
  3. Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, Craft D, Deye G, Riddell S, Lindler LE, Pitt TL. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol. 2006 Jul; 44(7):2630-4.

Oral and Poster Presentations / Published Abstracts:

13th International HIV Dynamics and Evolution Meeting, 5-8 April 2006,
Marine Biology Laboratories, Woods Hole, Massachusetts.

Oral Presentations:

Development And Application Of Multi-Region Subtype Specific Pcr (Mssp) Assay For Hiv-1 Subtypes B, C, CRF01_Ae, Their Recombinant Forms, And Dual Infections.
Supachai Sakkhachornphop, Sodsai Tovanabutra, Gustavo Kijak, Chris Beyrer, Eric Sanders-Buell, Myat Htoo Razak, Vinai Suriyanon, Jaroon Jittiwutikarn, Thira Sirisanthana, Merlin L. Robb , Deborah L. Birx , David D Celentano , and Francine E. McCutchan.

Breakpoint.Blast: A Database of HIV-1 Recombinant Structures and Breakpoints.
Gustavo H Kijak, Sodsai Tovanabutra, Eric Sanders-Buell, Miguel Arroyo, Sucheep Piyasirisilp, Merlin L Robb, Debora L Birx, and Francine E McCutchan.

In vivo HIV-1 Hypermutation:Levels and Patterns in 24 Hypermutated Complete Genome Sequences from Multiple Clades.
Gustavo H Kijak, Mario Janini, Sodsai Tovanabutra, Merlin L Robb, Deborah L Birx, and Francine E McCutchan

The 13 Conference on Retrovirus and Opportunistic Infections 5-8 February 2006
Denver, Colorado

Sensitivity of Multispot among HIV-1 Positive Patients with Various Levels of Exposure to Highly Active Antiretroviral Therapy
O'Connell, R. Stephanie A, Jennifer Malia, Nelson M.

In vivo fitness of enfuvirtide-resistant HIV-1 estimated by allele-specific PCR during partial treatment interruption and pulse intensification.
Marconi V, Bonhoeffer, S, Paredes R, Lu J, Hoh R, Martin J, Deeks S.

Resistance to Lamivudine in Adults with Multidrug-Resistant HIV-1 Infection Interrupting Treatment with Reverse Transcriptase Inhibitors (RTIs).
Paredes R, Marconi V, Hoh R, Martin J, Petropoulos C, Deeks S, Kuritzkes DR Prolonged Persistence of M184V Mutation and Phenotypic.

The Clinical Efficacy of Hepatitis B Vaccine in HIV-1-infected Individuals.
Michael Landrum, M Rasnake, W Bradley, C Murray, M Dolan, and B Agan.

The Effect of HIV Subtype on Rapid Disease Progression in Rakai, Uganda
Oliver Laeyendecker, X Li, M Arroyo, F McCutchan, R Gray, M Wawer, D Serwadda, F Nalugoda, G Kigozi, T Quinn, and Rakai Hlth Sci Prgm.

The Molecular Epidemiology of a Heterosexual Subtype B HIV Epidemic: the Latest Results from the Caribbean
Jean Carr, Y Nadai, L Eyzaguirre, M Charurat, A Sill, N Jack, F Cleghorn, W Pape, E Guerrer, and W Blattner

The Emerging Epidemics of HIV-1 and HCV among Injecting Drug Users in Tajikistan
C Beyrer, J Carr, J Stachowiak, F Tishkova, M Stibich, A Latypov, M Saad, Z Patel1, S Strathdee, and Alena Peryshkina

Prevalence and Risk Factors of Hypogonadism among HIV-infected Men
Nancy Crum-Cianflone, M Bavaro, B Hale, A Truett, T Powell1, S Medina1, C Brandt, B Pope, K Furtek, M Wallace, and on behalf of the TriSvc AIDS Clin Consortium

Erectile Dysfunction among HIV-infected Men
Nancy Crum-Cianflone, B Hale, M Bavaro, A Truett, S Medina, C Brandt, B Pope, K Furtek, P Olson, M Wallace, and the TriSvc AIDS Clin Consortium

HIV Pathogenesis and HIV Vaccines, Keystone Symposia, March 27 - April 2, 2006
Keystone, Colorado

Oral Presentations:

Preventive Vaccine Trial
Session: Clinical Trials: Prophylactic Vaccines
COL Nelson Michael

DC Vaccinations with HIV Antigens in Humans
Session: Antigen Presentation and Dendritic Cells
Dr. Mary Marovich

Posters:

Discordant Transcriptional Regulation of CXCR4 and CCR5 Expression in Primary Human Lymphocytes by Corticosteroids
P.K. Ehrenberg, Z. Wang, J. Ring, C.Y. Kil1, M. Vahey, and N.L. Michael.

Broad and potent cellular immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use
Andreas Bråve, Erik Rollman, Andreas Boberg, Deborah Birx, Josephine Cox, Merlin Robb, Charlotta Nilsson, Eric Sandström, Gunnel Biberfeldt, and Britta Wahren

XVI International AIDS Conference 13-18 August 2006
Toronto, Canada

Oral Presentations:

USMHRP Capacity Building Partnerships for the Future: AIDS Vaccine Research in the Developing World
COL Nelson L. Michael

The Link Between Multiple HIV-1 Exposure and Genetic Complexity of Strains is Reinforced by Identification of a Second Circulating Recombinant Form among Injecting Drug Users in Northern Thailand.
Sodsai Tovanabutra

Male Circumcision and HIV Infection Risk among Tea Plantation Residents in Kericho, Kenya: Incidence Results After 1.5 Years of Follow-Up
Douglas N. Shaffer, MD, MHS

Posters:

Recent Uptake of Injection and Frequent Needle Sharing Correlate with the Genetic Complexity of HIV-1 Strains Among Northern Thailand Injecting Drug Users
Authors: Sodsai Tovanabutra, Gustavo Kijak, Chris Beyrer, Teerada Sripaipan, Vinai Suriyanon, Nasheed Moqueet, Eric Sanders-Buell, Kittipong Rungruengthanakit, Jaroon Jittiwutikarn, Merlin Robb, Deborah L. Birx, David D. Celentano, Francine E. McCutchan

HIV Incidence Rate Trends among White and African-American Active Duty United States Army Personnel: 1986-2003
Authors: Sateren WB, Bautista CT, Sanchez JL, Singer DE, Scott P, Birx DL.

Syphilis and Malaria Incidence among Rural Tea Plantation Residents in Kericho, Kenya: Results of an HIV Cohort Study
Authors: Bautista CT, Sateren WB, Shaffer DN, Foglia G, Wassuna M, Kiplangat S, Sawe F, Kiptoo F, Kibaya R, Robb ML, Michael N, Birx DL. (2006) Poster Presentation No. TUPE0301 at the XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006.

20 Years of HIV Testing among U.S. Military Populations: HIV Prevalence among Civilian Applicants for U.S. Military Service, U.S. Army, Air Force, Navy, Marine Corps Personnel
Authors: Bautista CT, Sateren WB, Scott P, Singer DE, Michael N.

Retention after 1.5 Years of Follow-Up among Tea Plantation Residents in an HIV Cohort Study in Kericho, Kenya
Authors: Shaffer D, Langat L, Wassuna M, Bautista CT, Sateren WB, Foglia G, Langat W, Michael N, Birx DL.

AIDS Vaccine 2006, August 29, September 1, 2006
Amsterdam, Netherlands

Oral Presentations:

Plenary: Global Epidemiology of HIV: Influence of Risk Factors and Social Networks on the Complexity and Relationships of Inter-Subtype Recombinant Strains in Asia and Africa.
Francine McCutchan, Ph.D. Late Breaker: Multigene, multiclade HIV-1 plasmid DNA prime and MVA boost is safe and highly immunogenic in healthy human volunteers.
Josephine Cox, Ph.D. This was presented by Eric Sandstrom of the Karolinska Institute on behalf of the collaboration between USMHRP and Karolinska.

Posters:

Evaluation of a plasmid DNA prime MVA boost vaccine regimen intended for Human Use
Authors: A. Bråve, K. Ljungberg, B. Moss, P. Earl, P. Blomberg , R. Stout, J. Cox, J. Hinkula and B. Wahren.

CD8 T Cell Recognition of Multiple Epitopes within Two Regions of Gag is Associated with the Maintenance of a Low Steady-state Viremia in HIV-1 Seropositives
Authors: Christof Geldmacher, Jeffrey R. Currier, Eva Herrmann, Martina Gerhardt, Antelmo Haule, Leonard Maboko, Deborah Birx, Francine McCutchan, Andreas Meyerhans, Josephine Cox and Michael Hoelscher.

Mapping and Cross-clade Evaluation of Nef-specific Cellular Immune Responses in HIV-1+ Argentinean Patients Experiencing Seroconvertion and Infected with BF URFs
Authors: G Turk, MM Gherardi, J Cox and H Salomon.

Cytotoxic T Lymphocyte Responses in Uninfected Adult Ugandan Volunteers enrolled in a Phase I Multiclade HIV-1 DNA Plasmid Vaccine Trial (VRC-HIVDNA009-00-VP).
Authors: M. Eller, L. Eller, M. Opollo, B. Ouma, P. Oballah, L. Galley, M. Robb, F. Wabire-Mangen, B. Graham, D. Birx, M. de Souza and J. Cox.

Multivalent Immune Cell Surface Carbohydrate Moieties Inhibit HIV-1 Primary Isolate Infection of Peripheral Blood Mononuclear Cells but Enhance Infection of TZM-bl Reporter Cells
Authors: A. Rosa Borges, L. Wieczorek, B.K. Brown, D.L. Birx, C.L. Schengrund, V. Polonis

Progress Towards Definition of HIV-1 Neutralization Serotypes: Broad and Potent HIV-1 Primary Isolate Neutralization using Polyclonal Antibodies from Subtype C Infection
Authors: BK Brown, L Wieczorek, C Bermudez, C Bautista, T Santelli Antonille, M Garcia, A Gillis, ML Robb, NL Michael, DL Birx, FE McCutchan, and VR Polonis

Social/demographic Variables Associated with Recombinants and Dual Infections in Injecting Drug Users in Northern Thailand
Authors: GH Kijak, C Beyrer, S Tovanabutra, T Sripaipan, V Suriyanon, J Jittiwutikarn, ML Robb, DL Birx, DD Celentano, and FE McCutchan

HIV-1 Prevalence and Subtype Distribution in HIV-1 Positive Volunteers Deferred from Enrollment in a Phase III Prime-Boost HIV-1 Vaccine Trial in Thailand
Authors: GH Kijak, S Tovanabutra , S Rerks-Ngarm, S Watanna, W Wiriyakijja, S Nitayaphan, C Eamsila, M de Souza, J Kim, DL Birx, and FE McCutchan

Necessity of Region-Specific Normal Reference Ranges for Conducting HIV Clinical Trials
Authors: L Eller, B Ouma1, M Eller, W Sateren, B Bagaya, P Oballah, P Naluyima, A Natwijuka, F Wabwire-Mangen, P Kataaha, M deSouza, N Michael, M Robb and H Kibuuka

Unique Challenges and Lessons Learned in HIV Vaccine Cohort Development in Kericho, Kenya
Authors: F Sawe, L Langat, S Kiplangat, M Wasunna, D Shaffer, D Chuma, R Ndirangu, S Martin, M Robb, N Michael, and D Birx

The Importance of Thorough and Continuous Informed Consent in HIV Cohort Studies: Experiences from the Kericho HIV Cohort Study
Authors: J Cheruiyot, L Langat, S Kiplangat, M Wasuuna, D Shaffer, M Robb, and D Birx.

Infectious Diseases Society of America, October12-15, 2006
Toronto, Ontario, Canada

Poster:

Biomarkers of Tuberculosis in Human Blood
Authors: Lesho E, Ooi G, Paik S, Murata, Y, Ferguson, E, Streker, T, Aronson N.

Immunodiagnostics and Immunomonitoring Research to Clinic Meeting, November 5-7th 2006
San Diego

Cautionary tales on the use of peptides and other reagents for immune monitoring assays